Department of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Department of Surgery, Saitama Medical Center, Jichi Medical University, Japan.
Pancreatology. 2019 Jul;19(5):686-694. doi: 10.1016/j.pan.2019.06.012. Epub 2019 Jun 22.
/Objectives: The objectives of this study were to identify the factors affecting patients' survival and the characteristics of five-year survivors of pancreatic ductal adenocarcinoma (PDAC) after pancreatectomy as well as to clarify the correlation between the development of postoperative complications and a five-year survival.
A total of 104 patients underwent pancreatectomy for PDAC between April 2005 and March 2013 with curative intent. Patients who survived for more than five years after pancreatectomy were classified as long-term survivors. Sixteen demographic and clinical variables and 10 pathological variables were comprehensively assessed for their associations with the patients' survival time and long-term survival.
The presence of preoperative comorbidity (OR: 1.65, 95% CI 1.02-2.67, p = 0.042), postoperative overall complications (OR: 1.78, 95% CI 1.03-3.10, p = 0.041), a lymph node positivity ratio of ≥0.2 (OR: 3.04, 95% CI 1.51-6.11, p = 0.002), and portal invasion (OR: 2.58, 95% CI 1.48-4.49, p = 0.001) were identified as independent factors affecting the patients' survival. The absence of postoperative overall complications was identified as an independent factor related to long-term survival in the multivariate analysis (OR: 0.08, 95% CI 0.01-0.82, p = 0.034).
The presence of preoperative comorbidity, postoperative overall complications, LNR ≥0.2, and portal invasion were prognostic factors affecting the patients' survival, and avoiding postoperative complications after pancreatectomy might contribute to the long-term survival of PDAC patients after pancreatectomy. The further improvement of surgical procedures and perioperative care in order to reduce the rate of postoperative complications should be attempted.
目的:本研究旨在确定影响胰腺导管腺癌(PDAC)患者生存的因素,以及分析接受胰腺切除术的 PDAC 五年生存患者的特征,并阐明术后并发症的发生与五年生存率之间的相关性。
对 2005 年 4 月至 2013 年 3 月期间接受胰腺切除术且具有治愈目的的 104 例 PDAC 患者进行研究。胰腺切除术后生存时间超过五年的患者被归类为长期生存者。综合评估了 16 项人口统计学和临床变量以及 10 项病理学变量与患者生存时间和长期生存的相关性。
术前合并症的存在(OR:1.65,95%CI 1.02-2.67,p=0.042)、术后总体并发症(OR:1.78,95%CI 1.03-3.10,p=0.041)、淋巴结阳性率≥0.2(OR:3.04,95%CI 1.51-6.11,p=0.002)和门静脉侵犯(OR:2.58,95%CI 1.48-4.49,p=0.001)被确定为影响患者生存的独立因素。多变量分析显示,术后无总体并发症是与长期生存相关的独立因素(OR:0.08,95%CI 0.01-0.82,p=0.034)。
术前合并症、术后总体并发症、LNR≥0.2 和门静脉侵犯是影响患者生存的预后因素,避免胰腺切除术后并发症可能有助于提高 PDAC 患者胰腺切除术后的长期生存率。应尝试进一步改进手术程序和围手术期护理,以降低术后并发症的发生率。